The process of combining medical and psychotherapeutic treatment to address the dependence on alcohol and drugs such as prescription drugs and street drugs is called rehabilitation. Addiction to alcohol and drugs is considered a chronic disease. If the addiction is untreated, it can have serious life threatening effects. Drug and alcohol addiction is treated with several steps such as detoxification, counselling, medication, and long term follow ups to avoid relapse. Withdrawal symptoms are serious such as sweat, nausea, and vomiting. Hence, addiction is considered treatable, but a complex process.
Read Report Overview: https://www.transparencymarketresearch.com/drug-alcohol-rehabilitation-market.html
The global drug and alcohol rehabilitation market is expected to expand at a significant growth rate during the forecast period. According to the National Institute on Alcohol Abuse and Alcoholism, 26.9% of people aged 18 and above were engaged in binge drinking in a month in 2015. Rising prevalence of alcoholism is likely to be a key factor driving the global market from 2017 to 2025. Increased usage of illegal drugs is another factor anticipated to propel the global market during the forecast period. Furthermore, rise in major depression disorders, surge in trend among youngsters toward drugs and alcohols, underage drinking, peer pressure, and self-medication are some of the factors projected to fuel the growth of the global drugs and alcohol rehabilitation market during the forecast period. Serious withdrawal symptoms of the treatment is a major factor anticipated to restrain the global market from 2017 to 2025.
Request Table of Content: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=28526
The global drugs and alcohol rehabilitation market can be segmented based on treatment, screening, end-user, and region. In terms of treatment, the global market can be segmented into counselling, medication, and behavioral treatment. The medication segment can be sub-segmented into opioid addiction, tobacco, alcohol, and others. The medication segment is expected to account for a significant share of the global market during the forecast due to increase in usage of illicit drugs, alcoholism, and self-medication. Based on screening, the global market can be divided into oral fluid drug screening, urine drug screening, breathe alcohol screening, hair analysis, and others. In terms of end-user, the global drugs and alcohol rehabilitation market can be segmented into rehabilitation centers and clinics, hospitals, and home care settings. The rehabilitation centers and clinics segment is anticipated to hold the largest share of the global market during forecast period due to factors such as increasing federal funding.
Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28526
The global drug and alcohol rehabilitation market is projected to expand at a significant growth rate across regions. Geographically, the global drug and alcohol rehabilitation market can be divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global market in terms of value. Factors attributed to the growth of the market in North America are increase in patients suffering from major depression, prevalence of unhealthy lifestyle, surge in drug trafficking, and peer pressure. Europe is anticipated to account for the second largest share of the global market due to highest number of alcoholism-related disorders in the region. The market in Asia Pacific is expected to experience high growth due to increase in alcohol usage.
To maintain a significant position in the global drug and alcohol rehabilitation market, the key players are adopting strategies such as mergers and acquisitions, robust research and development, and geographical expansion. Major players operating in the global drug and rehabilitation market are Indivior, Inc., West-Ward Pharmaceuticals Corp., and Pfizer, Inc., among others.
General surgery devices are used for a wide variety of diseases. These devices are employed for routine procedures or in complicated surgeries. Over the time, several innovative devices have been invented for serving a particular purpose with more ease while performing surgeries and for reducing discomfort after the surgery. General surgery devices are used in gastrointestinal problems, trauma and burn care, hernias, and breast cancer. These devices are employed in several sub-specialties of general surgery such as orthopedics, obstetrics, neurology, urology, cardiovascular, and gynecology. The key purpose of general surgery devices is to cut, clamp, grasp, tie, and spread anatomical parts of the human body during surgical procedures. These devices are deployed primarily in hospitals, small clinics, and health care centers.
Read Report Overview: https://www.transparencymarketresearch.com/general-surgery-devices-market.html
The increasing number of geriatric patients worldwide, awareness among patients about different surgeries and minimally invasive procedures, technological developments in surgical procedures such as robotic and power-assisted systems are factors likely to fuel the general surgery devices market in the next few years. One of the technological developments is that the market is witnessing preference to minimally invasive procedures and use of robotics and computer-assisted devices, thereby reducing time required for surgery as well as complications. This has opened new avenues for growth of the global general surgery devices market. Market players are competing with one another with new product launches, expanding geographic presence, and innovative and educational offerings. However, the market is also facing challenges such as development of other non-invasive surgery technologies and intense competition among existing manufacturers of general surgery devices. Moreover, factors such as product recalls, government regulations regarding reduction in overall health care costs, and subsequent increase in bulk purchasing through INHs (Integrated Health Networks) and GPOs (group purchasing organizations) are restraining the market.
Request Table of Content: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=30332
The general surgery market have been segmented by product, application, and geography. In terms of product, it can be segmented into disposable surgical supplies, reusable, minimally invasive surgery instruments, energy-based and power devices, adhesion prevention products, and medical robotics and computer-assisted surgery devices. Among them, the disposable surgical supplies segment leads the market, due to rising demand for disposable needles, syringes, and catheters.
Geographically, the general surgery devices market can be classified into North America (U.S. and Canada), Europe (Germany, France, the U.K., etc.), Asia Pacific (Australia, China, Japan, and India), Latin America, and Middle East & Africa. The emerging markets in Asia Pacific, Latin America, and Middle East & Africa are expected to witness robust growth during the forecast period. North America leads the global market, holding the maximum share. This can be attributed to strong policy support of governments, favorable reimbursement policies, and the increase in demand for surgeries led by lifestyle-related diseases in the region. However, in terms of growth rate, Asia Pacific is likely to surpass all other regions in the next few years, due to the increasing expenditure on health care in developing countries of the region. Some of the prominent markets in Asia Pacific are India, Japan, China, Australia, and Singapore.
Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30332
Some of the key players operating in the global market for general surgery devices are B. Braun Melsungen AG, Boston Scientific Corporation, Smith & Nephew, Covidien Plc (Medtronic), Integra LifeSciences, Conmed Corporation, 3M Healthcare, CareFusion Corporation Ethicon, Inc. (Johnson & Johnson), Integra LifeSciences, Erbe Elektromedizin GmbH, TransEnterix, Inc., and Integer Holdings Corporation.
Mammography system is a special imaging medical device that helps detect breast cancer or breast-related diseases in women experiencing symptoms such as nipple discharge, skin dimpling, pain, or lump. This is done by the use of lower dose of X-rays and ionizing radiations. Even before the women experience symptoms of cancer, the mammography system is useful in detection. Mammography system shows changes in breast up to two years before a physician or a patient can feel them. A mammography system is a box with a tube to produce X-rays. According to the Breast Cancer Organization, globally, breast cancer is one of the significant health issues among women, as more than 30% (over 3.1 million women in the U.S.) were anticipated to have breast cancer among the cancer diagnosed patients in 2017. Among the women in the U.S., other than skin cancer, breast cancer is the most prevalent disease as about 85% of women diagnosed with breast cancer have no family history of the disease.
Read Report Overview: https://www.transparencymarketresearch.com/mammography-systems-market.html
Increased awareness about early detection of breast cancer and related disorders due to proactive initiatives by health care organizations, rise in geriatric population, increased prevalence of breast cancer, advancements in research and technological developments such as breast tomosynthesis, rise in government funding for breast cancer, and improved reimbursement insurance policies drive the global mammography systems market. However, generation of false negative or positive results and radiation exposure risks are anticipated to restrain the global mammography systems market.
The global mammography systems market can be segmented based on product type, technology, end-user, and region. In terms of product type, the market can be divided into breast tomosynthesis systems, analog mammography systems, and digital mammography systems, which can be sub-divided into digital radiography systems and computed radiography systems. The digital mammography systems segment held significant market share in 2016 owing to technological advancements. The breast tomosynthesis systems segment is anticipated to gain market share during the forecast period due to FDA approval for safe levels of radiation from mammograms, benefits such as clearer images, greater likelihood of detecting multiple breast tumors, fewer unnecessary additional tests or biopsies, greater accuracy, and early detection.
Request Table of Content: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=30467
Based on technology, the global mammography systems market can be segmented into 3-D mammography, 2-D mammography, and combined 2-D and 3-D mammography. The 3D mammography segment accounted for large market share in 2016 owing to factors such as false alarm, and the Medical Imaging Modernization Act, 2015. The combined 2-D and 3-D mammography segment is anticipated to grow in the next few years due to increasing awareness and government initiatives for breast cancer.
In terms of end-user, the global mammography systems market can be classified into ambulatory surgical centers and inpatient settings. Geographically, the global mammography systems market can be segmented into Asia Pacific, Europe, North America, Latin America, and Middle East & Africa. North America held significant market share in 2016 due to rise in population of women above 40 years, number of mammography units in diagnostic centers and hospitals, reimbursement coverage by governments, and sophisticated health care facilities. The market in Asia Pacific is anticipated to grow during the forecast period driven by high prevalence of breast cancer due to change in lifestyle of women in emerging countries such as China and India.
Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=30467
The major companies in the global mammography systems market include Siemens Healthcare GmbH, FUJIFILM Corporation, General Electric Company, Koninklijke Philips N.V., Analogic Corporation, and other prominent players are Toshiba Medical Systems Corporation, Planmed Oy, Konica Minolta, Inc., Hologic, Inc., Carestream Health, Tualatin Imaging, P.C., Micrima Limited, Delphinus Medical Technologies, Inc., and Aurora Imaging Technology, Inc.
An antiseptic is a chemical agent that destroys or inhibits microorganisms on living tissue such as oral cavities, skin, and open wound. A few antiseptics are capable of destroying microorganisms and are termed as bactericidal (hydrogen peroxide, mercurochrome). Only a few of these are capable of preventing or inhibiting the growth of microorganisms and are termed as bacteriostatic (alcohol, phenol). Primary application areas of antibiotics include hospitals, clinics, laboratories, and households. Examples of antiseptic liquid include alcohol, phenol, quaternary ammonium compound, brilliant green, hydrogen peroxide, iodine solution, polyhexanide, and sodium bicarbonate. Hand sanitizers are liquid antiseptics widely used to keep hands clean and avoid illnesses such as flu. Using hand sanitizers before eating and before working on a patient or an open wound can significantly reduce the chances of contamination for the patient. First aid antiseptics help relieve pain and prevent infection in cases of minor cuts, scrapes, and burns. Common active ingredients in antiseptic products are benzethonium chloride, benzalkonium chloride, lidocaine hydrochloride, benzocaine, and ethyl alcohol.
Read Report Overview: https://www.transparencymarketresearch.com/antiseptic-first-aid-liquids-market.html
The global antiseptic first aid liquids market is growing rapidly driven by increase in number of surgeries performed for various diseases and disorders. Growth of the market in terms of revenue is attributed to outbreak of infectious diseases such as swine flu. Such incidences have increased public awareness about the potential dangers of such infections. Rise in public awareness also boosts market growth primarily in the developed countries. Furthermore, rise in the number of hospitals, health care centers, and advanced health care facilities are likely to propel the global antiseptic first aid liquids market. Also, an increase in awareness and knowledge regarding precautions to be taken to prevent from flu, bacterial and other viral infections have driven the growth of this market. However, saturated market and stringent regulations in the developed economies are likely to restrain the antiseptic first aid liquids market.
Request Table of Content: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=31307
Various chemical compounds are used as antiseptic first aid liquids. Hence, these are categorized based on chemical composition. The global antiseptics first aid liquids market can be segmented based on chemical compound and end-user. In terms of chemical compound, the market can be categorized into alcohols and aldehydes, amides and biguanides, quaternary ammonium compounds, phenol and its derivatives, iodine compounds, and others. The alcohol and aldehyde derived segment is projected to account for the largest market share, followed by the amide and biguanide segment. Examples of antiseptic first aid active ingredients are camphorated phenol, benzethonium chloride, iodine, chloroxylenol, and povidone-iodine. In terms of end-user, the market can be segmented into hospitals and household.
Geographically, the global antiseptic first aid liquids market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America and Europe dominate the global market due to increased awareness among people. Asia Pacific and MEA hold the third and fourth positions in the global antiseptic first aid liquids market due to lack of awareness in some remote areas in the developing and underdeveloped nations.
Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=31307
Key players in the global antiseptic first aid liquids market include Ayuroma International Pte. Limited, Schulke & Mayr UK Ltd., Pascal International, Inc., Zhermack SpA, Dynarex Corporation, Dexcel Pharma GmbH, Reckitt Benckiser, Huckert International, and Sirmaxo Chemicals Private Limited.
High performance liquid chromatography (HPLC) is one of the techniques used to separate, quantitate, and identify components in the given mixture. It is considered one of the powerful tools in analytical chemistry. HPLC is a type of column chromatography in which the solvent containing the sample mixture is passed through a column containing adsorbent material, using a pressure pump. The component in the sample reacts differently with the adsorbent material, leading to different flow rates of different components, thus separating the mixtures. This process is faster as compared to other chromatography procedures.
The global HPLC market is expected to expand at a robust CAGR over the forecast period. Greater sensitivity and higher accuracy as compared to conventional chromatographic techniques are the significant factors likely to drive the growth of the global HPLC market over the forecast period. Higher penetration rate of HPLC, increased popularity of LC-MS (liquid chromatography- mass spectrography), surge in usage of HPLC in pharmaceuticals for quality control testing and manufacturing, faster results and separation, and technical advancement are some of the other factors propelling growth of the global market through 2025. Furthermore, growing number of pharmaceuticals in developing and developed countries is anticipated to drive the growth of the global HPLC market. However, high cost of the instrument and lack of expert analysts are factors restraining the growth of the global high performance liquid chromatography market.
Request Table of Content: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=28322
The global HPLC market can be segmented on the basis of product type, application, end users, and region. On the basis of product type, the market can be segmented into instruments, consumables, and accessories. The consumable segment is expected to register highest share during the forecast period, due to its high usage. The instrument segment can be sub segmented into pressure pumps, detectors, fraction collectors, systems and others. Based on application, the global HPLC market is divided into diagnostics, manufacturing and quality control testing, clinical research, forensics and other application. The manufacturing and quality testing segment is anticipated to register considerable market share during the forecast period due to faster results with greater accuracy and higher sensitivity. Based on end users, the global HPLC market can be divided into pharmaceutical industries, academic and research institutes, diagnostic laboratories and others. The pharmaceutical industries segment is expected to register the highest growth during the forecast period due to rise in number of industries.
Download Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28322
The global HPLC market is projected to expand at a significant rate across regions. Geographically, the global HPLC market is divided into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is the dominating region in the global HPLC market in terms of value and volume. The factors attributed to the growth of the market in North America are – developed healthcare infrastructure, increase in number of industries over a period, high adoption rate of technologically advanced products, rise in healthcare expenditure, and expertise and research activities in the region. Asia Pacific is expected to witness higher growth in the global HPLC market due to factors such as newer technology, rise in disposable income, and increasing funding for research activities.
To maintain a significant position in the global HPLC market, key players are following strategies such as developing user friendly and cost effective products, mergers and acquisitions, robust research and development, geographical expansion etc. Some of the prominent players operating in the global HPLC market include GE Healthcare, WATERS, Bio-Rad Laboratories, Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc, Gilson, Inc., and Higgins Analytical, Inc.